AngioDynamics Analyst Ratings
AngioDynamics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/05/2023 | 140.79% | Canaccord Genuity | $20 → $17 | Maintains | Buy |
| 10/05/2023 | 183.29% | HC Wainwright & Co. | $19 → $20 | Maintains | Buy |
| 09/25/2023 | 169.12% | HC Wainwright & Co. | → $19 | Initiates Coverage On | → Buy |
| 07/13/2023 | 183.29% | Canaccord Genuity | $18 → $20 | Maintains | Buy |
| 04/17/2023 | 84.14% | Raymond James | $14 → $13 | Downgrades | Strong Buy → Outperform |
| 04/03/2023 | 98.3% | Raymond James | $22 → $14 | Maintains | Strong Buy |
| 01/06/2023 | 211.61% | Raymond James | $25 → $22 | Maintains | Strong Buy |
| 10/07/2022 | 254.11% | Raymond James | $27 → $25 | Maintains | Strong Buy |
| 07/13/2022 | 282.44% | Raymond James | $32 → $27 | Maintains | Strong Buy |
| 10/15/2021 | 424.08% | Canaccord Genuity | $28 → $37 | Upgrades | Hold → Buy |
| 08/20/2021 | — | Oppenheimer | Initiates Coverage On | → Perform | |
| 07/14/2021 | 296.6% | Canaccord Genuity | $24 → $28 | Maintains | Hold |
| 07/09/2021 | 353.26% | Raymond James | $27 → $32 | Maintains | Strong Buy |
| 03/31/2021 | 239.94% | Canaccord Genuity | $18 → $24 | Maintains | Hold |
| 01/08/2021 | 239.94% | Raymond James | $18 → $24 | Maintains | Strong Buy |
| 11/25/2020 | 154.96% | Raymond James | → $18 | Upgrades | Market Perform → Strong Buy |
| 04/08/2020 | 98.3% | Canaccord Genuity | $18 → $14 | Maintains | Hold |
| 04/08/2020 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 10/04/2019 | 197.45% | Keybanc | $30 → $21 | Maintains | Overweight |
| 01/07/2019 | 225.78% | Canaccord Genuity | $20 → $23 | Maintains | Hold |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/05/2023 | 140.79% | 卡納科特·格納奇 | $20→$17 | 維護 | 買 |
| 10/05/2023 | 183.29% | HC Wainwright公司 | $19→$20 | 維護 | 買 |
| 09/25/2023 | 169.12% | HC Wainwright公司 | →$19 | 開始承保 | →購買 |
| 07/13/2023 | 183.29% | 卡納科特·格納奇 | $18→$20 | 維護 | 買 |
| 04/17/2023 | 84.14% | 雷蒙德·詹姆斯 | $14→$13 | 評級下調 | 強勢買入→跑贏大盤 |
| 04/03/2023 | 98.3% | 雷蒙德·詹姆斯 | $22→$14 | 維護 | 強勢購買 |
| 01/06/2023 | 211.61% | 雷蒙德·詹姆斯 | $25→$22 | 維護 | 強勢購買 |
| 10/07/2022 | 254.11% | 雷蒙德·詹姆斯 | $27→$25 | 維護 | 強勢購買 |
| 07/13/2022 | 282.44% | 雷蒙德·詹姆斯 | $32→$27 | 維護 | 強勢購買 |
| 2021年10月15日 | 424.08% | 卡納科特·格納奇 | $28→$37 | 升級 | 持有→購買 |
| 08/20/2021 | - | 奧本海默 | 開始承保 | →性能 | |
| 07/14/2021 | 296.6% | 卡納科特·格納奇 | $24→$28 | 維護 | 保持 |
| 07/09/2021 | 353.26% | 雷蒙德·詹姆斯 | $27→$32 | 維護 | 強勢購買 |
| 03/31/2021 | 239.94% | 卡納科特·格納奇 | $18→$24 | 維護 | 保持 |
| 01/08/2021 | 239.94% | 雷蒙德·詹姆斯 | $18→$24 | 維護 | 強勢購買 |
| 11/25/2020 | 154.96% | 雷蒙德·詹姆斯 | →$18 | 升級 | 市場表現→強勁買入 |
| 04/08/2020 | 98.3% | 卡納科特·格納奇 | $18→$14 | 維護 | 保持 |
| 04/08/2020 | - | KeyBanc | 評級下調 | 增持→板塊權重 | |
| 2019/10/04 | 197.45% | KeyBanc | $30→$21 | 維護 | 超重 |
| 2019年07月01日 | 225.78% | 卡納科特·格納奇 | $20→$23 | 維護 | 保持 |
What is the target price for AngioDynamics (ANGO)?
AngioDynamics(Ango)的目標價是多少？
The latest price target for AngioDynamics (NASDAQ: ANGO) was reported by Canaccord Genuity on October 5, 2023. The analyst firm set a price target for $17.00 expecting ANGO to rise to within 12 months (a possible 140.79% upside). 8 analyst firms have reported ratings in the last year.
Canaccel Genuity於2023年10月5日報道了AngioDynamic(納斯達克代碼：ANGO)的最新目標價。這家分析公司將目標價定為17美元，預計Ango將在12個月內上漲(可能上漲140.79%)。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for AngioDynamics (ANGO)?
AngioDynamic(Ango)的最新分析師評級是多少？
The latest analyst rating for AngioDynamics (NASDAQ: ANGO) was provided by Canaccord Genuity, and AngioDynamics maintained their buy rating.
對AngioDynamic(納斯達克代碼：ANGO)的最新分析師評級由Canaccel Genuity提供，AngioDynamic維持其買入評級。
When is the next analyst rating going to be posted or updated for AngioDynamics (ANGO)?
AngioDynamics(Ango)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AngioDynamics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AngioDynamics was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與AngioDynamic的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。AngioDynamics的上一次評級是在2023年10月5日提交的，所以你應該預計下一次評級將在2024年10月5日左右的某個時候提供。
Is the Analyst Rating AngioDynamics (ANGO) correct?
分析師對AngioDynamics(Ango)的評級正確嗎？
While ratings are subjective and will change, the latest AngioDynamics (ANGO) rating was a maintained with a price target of $20.00 to $17.00. The current price AngioDynamics (ANGO) is trading at is $7.06, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的AngioDynamics(Ango)評級維持不變，目標價在20.00美元至17.00美元之間。AngioDynamics(Ango)目前的股價為7.06美元，超出了分析師的預測區間。